>
Doug Casey on America's Fading Hegemony and the New World Order
Are Muslims burning down Japan's sacred shrines and temples?
Men are finally back in the driver's seat, and women are pissed about it…
Watch: Christian Preachers Kicked Out Of Burning Man For Spreading Gospel Of Jesus Christ
Here's What to Expect as Air Taxis Actually Begin to Take Off
'Wood Foam' Startup Uses Logging Waste as Substitute for Plastic, Producing 400 Pounds Daily
How a Group of Young Men in 1933 Solved a Water Crisis in The Desert -- And Nobody Knows About It
This American Battery Could Break China's Grip On The EV Supply Chain
Tesla's Cybercab Launch Is Next Week. Here's What Tesla Still Needs To Prove
800-passenger commercial plane boldly reinvents how we will fly
Does Ultra-Fast Charging Ruin An EV Battery? BYD Did It 350 Times In 9 Days To Find Out
Singapore is experimenting with biological computing using living human neurons...
It's Happening - Europe is Building an Impossible Fusion Reactor
Portable 1MW Kaleidos Microreactor Secures Critical Nuclear Fuel Deal Through 2030s

Epidemiologist Nicolas Hulscher on Brannon Howse Live
Yesterday, I joined Brannon Howse Live to share some long-overdue good news. We discussed emerging breakthroughs in cancer research, the extraordinary promise of natural compounds like dandelion root and high-dose vitamin C, and a major development in the mRNA arena:
Dandelion Root Extract: A Common Weed With Anti-Cancer Power
·
Dec 9
A remarkable peer-reviewed study found that aqueous dandelion root extract kills 95% of cancer cells in vitro and reduces human colon tumor growth by over 90% in mice — with zero toxicity.
Tumors in untreated mice grew aggressively.
Tumors in the treated group barely grew at all.
Human trials were planned but mysteriously never funded — likely because a common backyard plant is not profitable for the chemo-industrial complex.
This study fits into a larger body of over 1,100 peer-reviewed papers showing anti-cancer effects from natural, non-toxic compounds — an entire therapeutic frontier long ignored because it threatens the economics of conventional oncology.